Where Global Innovation
and Capital Meet

Page 3

Icosavax lands on $182m IPO

UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

Aug 2, 2021

Tenaya tends to $180m IPO

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

Aug 2, 2021

IN8Bio initiates $40m IPO

IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.

Jul 31, 2021

Duolingo brings in $521m IPO

Carnegie Mellon-linked Duolingo raised $521m in an upsized offering and saw its shares rise 36% on their first day.

Jul 29, 2021

Sema4 secures Nasdaq listing

Icahn School of Medicine spinout Sema4 has completed a reverse merger with CM Life Sciences to begin trading on the Nasdaq Global Select Market.

Jul 29, 2021

Sophia Genetics secures $234m in IPO

Genomics analytics platform developer Sophia Genetics has gone public ten years after it was co-founded by researchers from EMBL, Stanford and University of Geneva

Jul 27, 2021

Caribou Biosciences careers on to public markets

UC Berkeley’s cancer therapy developer priced a $304m initial public offering at the top of its range.

Jul 23, 2021

IsoPlexis applies itself to IPO filing

Yale University is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.

Jul 23, 2021

Kin to clinch public markets spot

The UChicago-backed digital home insurance provider is joining forces with Omnichannel Acquisition Corp at a valuation of just over $1bn.

Jul 20, 2021

TScan takes in $100m through IPO

Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.

Jul 19, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here